Induction of cellular differentiation and apoptosis by signal transduction inhibitors

Advances in Enzyme Regulation

Volumn 37, Issue , 1997, Pages 393-401

  Umezawa, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DEPHOSTATIN; 3-DEAZAADENOSINE; ADENOSINE; ANTINEOPLASTIC AGENT; ARISTEROMYCIN; DEPHOSTATIN; DRUG DERIVATIVE; ERBSTATIN; FORMYCIN; FORMYCIN DERIVATIVE; HYDROQUINONE DERIVATIVE; NERVE GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; TUBERCIDIN; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; APOPTOSIS; CANCER CELL CULTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN K 562; CHEMICAL STRUCTURE; CONFERENCE PAPER; DNA DEGRADATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; ONCOGENE; PATHOLOGY; PHEOCHROMOCYTOMA; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; FORMYCINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ABL; HUMANS; HYDROQUINONES; MOLECULAR STRUCTURE; NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION; TUBERCIDIN; TUMOR CELLS, CULTURED;

ANIMALIA; STREPTOMYCES;

EID: 0030866851     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(96)00022-2     Document Type: Conference Paper

References (19)

1. 1. K. UMEZAWA, Isolation and biological activities of signal transduction inhibitors from microorganisms and plants, Advan. Enzyme Regul. 35,43-53 (1995).
2. 2. J. KNOPKA and O. N. WITTE, Activation of the abl oncogene in murine and human leukemias, Biochim. Biophys. Acta 823, 1-17 (1985).
3. 3. Y. HONMA, J. OKABE-KADO, M. HOZUMI, I. Y. UEHARA and S. MIZUNO, Induction of erythroid differentiation of K562 human leukaemic cells by herbimycin A, an inhibitor of tyrosine kinase activity, Cancer Res. 49, 331-334 (1989).
4. 4. Y. HONMA, J. OKABE-KADO, T. KASUKABE, M. HOZUMI and K. UMEZAWA, Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukaemia K562 cells, Jap. J. Cancer Res. 81, 1132-1136 (1990).
5. 5. T. KUSAKA, H. YAMAMOTO, M. SHIBATA, M. MUROI, T. KISHI and K. MIZUNO, Streptomyces citricolor Nov. sp. and a new antibiotic, aristeromycin, J. Antibiot. 21, 255-263 (1968).
6. 6. Y MIZUTANI, S. MASUOKA, M. IMOTO, M. KAWADA and K. UMEZAWA, Induction of erythroid differentiation in leukaemic K562 cells by an S-adenosylhomocysteine hydrolase inhibitor, aristeromycin, Biochem. Biophys. Res. Commun. 207, 69-74 (1995).
7. 7. M. IMOTO, H. KAKEYA, T. SAWA, C. HAYASHI, M. HAMADA, T. TAKEUCHI and K. UMEZAWA, Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces I. Taxonomy, isolation, and characterization, J. Antibiot. 46, 1342-1346 (1993).
8. 8. T. WATANABE, T. TAKEUCHI, M. OTSUKA and K. UMEZAWA, Total synthesis of dephostatin, a novel protein tyrosine phosphatase inhibitor, J. Chem. Soc. Chem. Commun. 4, 437-438 (1994).
9. 9. T. WATANABE, T. TAKEUCHI, M. OTSUKA, S. TANAKA and K. UMEZAWA, Synthesis and protein tyrosine phosphatase inhibitory activity of dephostatin analogs, J. Antibiot. 48, 1460-1466 (1995).
10. 10. S. COWLEY, H. PATERSON, P. KEMP and C. J. MARSHALL, Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells, Cell 77, 841-852 (1994).
11. 11. K. UMEZAWA and M. IMOTO, Use of erbstatin as a protein-tyrosine kinase inhibitor, Meth. Enzymol. 201, 379-385 (1991).
12. 12. M. IMOTO, K. UMEZAWA, K. KOMURO, T. SAWA, T. TAKEUCHI and H. UMEZAWA, Antitumor activity of erbstatin, a tyrosine protein kinase inhibitor, Jap. J. Cancer Res. (Gann) 78, 329-332 (1987).
13. 13. S. SIMIZU, M. IMOTO, N. MASUDA, M. TAKADA and K. UMEZAWA, Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells, Cancer Res. 56, 4978-4982 (1996).
14. 14. C. A. EVANS, P. J. OWEN-LYNCH, A. D. WHETTON and C. DIVE, Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells, Cancer Res. 53, 1735-1738 (1993).
15. 15. A. J. MCGAHON, W. K. NISHIOKA, S. J. MARTIN, A. MAHBOUBI, T. G. COTTER and D. R. GREEN, Regulation of the Fas apoptotic cell death pathway by Abl, J. Biol. Chem. 270, 22625-22631 (1995).
16. 16. N. MEYDAN, T. GRUNBERGER, H. DADI, M. SHAHAR, E. ARPAIA, Z. LAPIDOT, J. S. LEEDER, M. FREEDMAN, A. COHEN, A. GAZIT, A. LEVITZKI and C. M. ROIFMAN, Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor, Nature (Lond) 379, 645-648 (1996).
17. 17. J. MARKOVITS, A. K. LARSEN, E. SEGAL-BENDIRDJIAN, P. FOSSE, J.-M. SAUCIER, A. GAZIT, A. LEVITZKI, K. UMEZAWA and A. JACQUEMIN-SABLON, Inhibition of DNA topoisomerase I and II and induction of apoptosis by erbstatin and tyrphostin derivatives, Biochem. Pharmacol. 48, 549-560 (1994).
18. 18. I. FATH, F. SCHWEIGHOFFER, I. REY, M.-C. MULTON, J. BOIZIAU, M. DUCHESNE and B. TOCQUE, Cloning of a Grb2 isoform with apoptotic properties, Science 264, 971-974 (1994).
19. 19. G. KROEMER, P. PETIT and N. ZAMZAMI, The biochemistry of programmed cell death, FASEB J. 9, 1277-1287 (1995).